Bictegravir/Emtricitabine/Tenofovir Alafenamide for HIV-1: What is the Hidden Potential of This Emerging Treatment?

Bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) is a single-tablet antiretroviral therapy regimen. B/F/TAF has become a popular treatment choice because of its small tablet size, high barrier to resistance, favorable tolerability, and limited drug–drug interaction profile. Continued resear...

Descripción completa

Detalles Bibliográficos
Autores principales: Januszka, Jenna E, Drwiega, Emily N, Badowski, Melissa E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693755/
https://www.ncbi.nlm.nih.gov/pubmed/38050483
http://dx.doi.org/10.2147/HIV.S385877

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693755/
https://www.ncbi.nlm.nih.gov/pubmed/38050483
http://dx.doi.org/10.2147/HIV.S385877

Ejemplares similares